Membranous Nephropathy with Proteinase 3-ANCA-associated Vasculitis Successfully Treated with Rituximab

被引:7
|
作者
Yoshida, Shun [1 ]
Hanai, Shunichiro [1 ]
Nakagomi, Daiki [1 ]
Kobayashi, Kei [1 ]
Takahashi, Kazuya [1 ]
Furuya, Fumihiko [1 ]
机构
[1] Univ Yamanashi, Dept Internal Med 3, Kofu, Yamanashi, Japan
关键词
small vessel vasculitis; glomerular disease; secondary membranous nephropathy; immune complex deposits; immunofluorescence staining; CRESCENTIC GLOMERULONEPHRITIS; MYELOPEROXIDASE; DEPOSITS; CYCLOPHOSPHAMIDE;
D O I
10.2169/internalmedicine.4752-20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Membranous nephropathy (MN) with anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (ANCA-GN) is seen infrequently. Previous reports of patients with ANCA-GN with MN showed that the most frequent ANCA subtype was myeloperoxidase-ANCA. We herein present a 73-year-old woman with scleritis, hematuria, proteinuria, and positive serum proteinase 3 (PR3)-ANCA. She underwent a renal biopsy and was diagnosed with MN and ANCA-GN. Immunofluorescence staining for PR3 colocalized with IgG along the glomerular basement membrane were observed. Oral prednisolone and intravenous rituximab therapy immediately improved her symptoms and urinalysis abnormalities. PR3-ANCA may be involved in the pathogenesis of MN via the formation of immune complexes.
引用
收藏
页码:145 / 150
页数:6
相关论文
共 50 条
  • [1] Membranous nephropathy with crescents associated with levamisole-induced MPO-ANCA vasculitis
    Moinuddin, Irfan
    Madhrira, Machaiah
    Bracamonte, Erika
    Thajudeen, Bijin
    Sussman, Amy
    PATHOLOGY RESEARCH AND PRACTICE, 2016, 212 (07) : 650 - 653
  • [2] A case of COVID-19-associated C-ANCA vasculitis, was successfully treated with rituximab therapy
    Filoramo, Michael
    Contractor, Renish
    Chandramohan, Deepak
    Singh, Prabhat
    Jena, Nihar
    Simhadri, Prathap Kumar
    CLINICAL CASE REPORTS, 2024, 12 (08):
  • [3] ANCA Associated Vasculitis Secondary to Levamisole-Adultered Cocaine with Associated Membranous Nephropathy: A Case Series
    Collister, David
    Sathianathan, Christie
    Ryz, Krista
    Karpinski, Martin
    Bernstein, Keevin
    Gibson, Ian W.
    AMERICAN JOURNAL OF NEPHROLOGY, 2017, 45 (03) : 209 - 216
  • [4] Rituximab in ANCA-Associated Vasculitis
    Hassan, Romina I.
    Gaffo, Angelo L.
    CURRENT RHEUMATOLOGY REPORTS, 2017, 19 (02)
  • [5] Infections in ANCA-associated vasculitis and lupus nephritis treated with rituximab
    Temiz, Sultan Gozde
    Barutcu Atas, Dilek
    Alibaz Oner, Fatma
    Velioglu, Arzu
    Hakki Arikan, Izzet
    Tuglular, Zubeyde Serhan
    Direskeneli, Rafi Haner
    Asicioglu, Ebru
    MARMARA MEDICAL JOURNAL, 2024, 37 (03): : 268 - 273
  • [6] Severe infections in patients with ANCA-associated vasculitis treated with rituximab
    Segelmark, Leo
    Flores-Suarez, Luis
    Mohammad, Aladdin
    RHEUMATOLOGY, 2022, 61 (01) : 205 - 212
  • [7] Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis
    Hilhorst, Marc
    van Paassen, Pieter
    Tervaert, Jan Willem Cohen
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (10): : 2314 - 2327
  • [8] Rituximab: effective in ANCA-associated vasculitis?
    Schoenermarck, Ulf
    de Groot, Kirsten
    NATURE REVIEWS NEPHROLOGY, 2011, 7 (01) : 6 - 8
  • [9] Rituximab to treat ANCA-associated vasculitis
    Guillevin, L.
    Mahr, A.
    REVUE DE MEDECINE INTERNE, 2011, 32 (10): : 591 - 593
  • [10] Rituximab in ANCA-associated vasculitis: a revolution?
    Tervaert, Jan Willem Cohen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (10) : 3077 - 3079